Sen. Wyden, Colleagues Renew Request for FDA to Address Concerns About Dangerous Pulse Oximeter Inaccuracies Affecting Communities of Color
August 13, 2022
August 13, 2022
WASHINGTON, Aug. 13 -- Sen. Ron Wyden, D-Oregon, issued the following news release and letter on Aug. 12, 2022:
U.S. Senator Ron Wyden this week with colleagues Senators Elizabeth Warren, D-Mass., Cory Booker, D-N.J., Ed Markey, D-Mass., and Tammy Duckworth, D-Ill., implored the U.S. Food and Drug Administration (FDA) to initiate a post market study of pulse oximeters to ensure they are effective across racially diverse patients and consumers.
Recent studies have shown . . .
U.S. Senator Ron Wyden this week with colleagues Senators Elizabeth Warren, D-Mass., Cory Booker, D-N.J., Ed Markey, D-Mass., and Tammy Duckworth, D-Ill., implored the U.S. Food and Drug Administration (FDA) to initiate a post market study of pulse oximeters to ensure they are effective across racially diverse patients and consumers.
Recent studies have shown . . .